Merkel cell carcinoma (MCC) is an extremely rare cutaneous neuroendocrine cancer, with an incidence approximately 40 times lower than that of malignant melanoma; however, its significantly inferior survival rate compared to melanoma establishes MCC as the most lethal form of skin cancer. In recent years, a substantial body of literature has demonstrated a gradual increase in the incidence of MCC. Although the two factors that contribute to MCC, ultraviolet radiation and Merkel cell polyomavirus infection, have been well established, the specific pathogenesis of this disease remains unclear. Additionally, considering the high lethality and recurrence rates of MCC, as well as the absence of specific antitumor drugs, it is crucial to elucidate the factors that can accurately predict patients' outcomes. In this review, we summarized the significant advancements in the epidemiological characteristics, pathogenesis, and the factors that influence patient prognosis of MCC to enhance clinical practices and public health efforts.
Keyphrases
- prognostic factors
- skin cancer
- public health
- risk factors
- end stage renal disease
- current status
- systematic review
- newly diagnosed
- chronic kidney disease
- healthcare
- ejection fraction
- primary care
- peritoneal dialysis
- single cell
- squamous cell carcinoma
- skeletal muscle
- radiation therapy
- insulin resistance
- patient reported outcomes
- mesenchymal stem cells
- weight loss
- squamous cell
- glycemic control